Holen Sie sich die Stockscreener-App
3.73
5.57%
-0.22
Handel nachbörslich:
3.42
-0.31
-8.31%
Schlusskurs vom Vortag:
$3.95
Offen:
$3.95
24-Stunden-Volumen:
145.90K
Relative Volume:
1.08
Marktkapitalisierung:
$48.20M
Einnahmen:
$257.55M
Nettoeinkommen (Verlust:
$11.95M
KGV:
4.0989
EPS:
0.91
Netto-Cashflow:
$-9.39M
1W Leistung:
-4.24%
1M Leistung:
-27.43%
6M Leistung:
-28.82%
1J Leistung:
-76.35%
1-Tages-Spanne:
$3.5001
$3.98
1-Wochen-Bereich:
$3.5001
$4.169
52-Wochen-Spanne:
$3.2101
$15.70
Eagle Pharmaceuticals Inc Stock (EGRX) Company Profile
Firmenname
Eagle Pharmaceuticals Inc
Sektor
Telefon
201-326-5300
Adresse
50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ
Eagle Pharmaceuticals Inc Stock (EGRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2018-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-31 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-03-21 | Bestätigt | Mizuho | Underperform |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-06 | Bestätigt | Mizuho | Underperform |
| 2017-07-27 | Bestätigt | Mizuho | Underperform |
| 2017-07-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-05-09 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-01-09 | Herabstufung | Mizuho | Neutral → Underperform |
| 2016-11-16 | Herabstufung | Mizuho | Buy → Neutral |
| 2016-11-03 | Hochstufung | Mizuho | Neutral → Buy |
| 2016-11-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-10-26 | Bestätigt | Mizuho | Buy |
| 2016-08-16 | Bestätigt | Mizuho | Neutral |
| 2016-06-20 | Herabstufung | Mizuho | Buy → Neutral |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-03-18 | Bestätigt | Mizuho | Buy |
| 2016-02-26 | Bestätigt | Mizuho | Buy |
| 2015-12-09 | Eingeleitet | Mizuho | Buy |
| 2015-07-29 | Bestätigt | Piper Jaffray | Overweight |
Alle ansehen
Eagle Pharmaceuticals Inc Aktie (EGRX) Neueste Nachrichten
173,365 Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Bought by Perceptive Advisors LLC - MarketBeat
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World
Bendamustine Market 2024 Growth Potential, Manufacturers, Production, Revenue and Forecast 2032 Teva, Eisai, Eagle Pharmaceuticals, MundiPharma – Cauverynews - Cauverynews
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - MarketBeat
Emergent Sinks on New Orders for Smallpox, Mpox Vaccine - Baystreet.ca
Emergent Biosolutions Shares Rise 16% on Orders Secured for Smallpox, Monkeypox Vaccines - MarketWatch
Fidelis Capital Partners LLC Purchases New Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Acadian Asset Management LLC Sells 26,056 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
First Eagle Investment Management LLC Grows Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Beta Blockers Global Market Report 2024: Size, Growth Rate, and Segments - WhaTech
From Rs 5.97 to Rs 47.25 per share in just 137 days: Debt-free multibagger penny stock hit back-to-back upper circuits & 52-week highs; Here’s why! - Dalal Street Investment Journal
StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
LSV Asset Management Reduces Stake in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Los Angeles Capital Management LLC Cuts Stock Position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - MarketBeat
StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals receives another delisting notice - NJBIZ
Vasopressin for Vasoplegic Shock Market: Advances in Vasopressin - WICZ
Is Eagle Pharmaceuticals Inc (EGRX) a good investment opportunity? - US Post News
Is Eagle Pharmaceuticals Inc (EGRX) positioned for future growth? - SETE News
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - MarketBeat
Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - Defense World
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Short Interest Update - MarketBeat
Eagle Pharmaceuticals faces potential Nasdaq delisting - Investing.com India
Eagle Pharmaceuticals faces potential Nasdaq delisting - Investing.com
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq - ForexTV.com
Eagle Pharmaceuticals Struggles with Financial Compliance and Nasdaq Listing - TipRanks
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq - StockTitan
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World
Investigation announced for Long-Term Investors in shares of Eagle Pharmaceuticals, Inc. (NADAQ: EGRX) - openPR
Price T Rowe Associates Inc. MD Purchases Shares of 15,748 Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Vanguard Group Inc. Acquires 2,630 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Price T Rowe Associates Inc. MD Takes Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Crosses Below Two Hundred Day Moving Average of $4.98 - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Shares Cross Below Two Hundred Day Moving Average of $4.98 - MarketBeat
Eagle Pharmaceuticals (NASDAQ:EGRX) Research Coverage Started at StockNews.com - MarketBeat
Eagle Pharmaceuticals (NASDAQ:EGRX) Research Coverage Started at StockNews.com - Defense World
StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - MarketBeat
Eagle Pharmaceuticals secures Nasdaq listing extension - Investing.com
Eagle Pharmaceuticals secures Nasdaq listing extension By Investing.com - Investing.com Canada
Jacobs Levy Equity Management Inc. Makes New $64,000 Investment in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Acadian Asset Management LLC Sells 235,109 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Acadian Asset Management LLC Sells 235,109 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - MarketBeat
Acadian Asset Management LLC Reduces Stock Holdings in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - MarketBeat
(EGRX) Proactive Strategies - Stock Traders Daily
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Shares Sold by BNP Paribas Financial Markets - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Receives New Coverage from Analysts at StockNews.com - Defense World
Headlands Technologies LLC Purchases 2,861 Shares of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Antiemetics Drugs Market Size & Share Report, 2024 – 2032 - Global Market Insights
Finanzdaten der Eagle Pharmaceuticals Inc-Aktie (EGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.23%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):